Endocrine treatment for breast cancers: Biological rationale and current progress
- 1 November 1990
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (4) , 467-480
- https://doi.org/10.1016/0960-0760(90)90390-7
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- Actions of oestrogens and antioestrogens on rat mammary gland development: Relevance to breast cancer preventionJournal of Steroid Biochemistry, 1988
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1986
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Estrone and estradiol content in human breast tumors: Relationship to estradiol receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1977
- Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.BMJ, 1975
- Influence of Synthetic Oestrogens on Advanced Malignant DiseaseBMJ, 1944
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896